Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 20 matching records.
20 results — page 1 of 1
- Level CRetrospective StudyEurope PMC
Comparative effectiveness of ustekinumab versus infliximab in the management of perianal fistulizing Crohn's disease: a retrospective study in China
Retrospective Study on Autoimmune Research, published in Intest Res (2026) — summary generated from the PubMed abstract.
- 2026
Intest Res1 citations - Level DNarrative ReviewEurope PMC
Advancement flaps in perianal fistulizing Crohn's disease: technical steps and current evidence
Narrative Review with a reported sample of 305 on Autoimmune Research, published in Tech Coloproctol (2026) — summary generated from the PubMed abstract.
- 2026
- n = 305
Tech Coloproctol - Level DNarrative ReviewPubMed
Needles for healing: stem cells, platelet-enriched plasma, and fat injection in perianal fistulizing Crohn's disease.
Narrative Review on Chronic Wound, Chronic Inflammation, Immune Modulation, Autoimmune Research, published in Tech Coloproctol (2026) — summary generated from the PubMed abstract.
- 2026
Tech Coloproctol - Level DNarrative ReviewEurope PMC
Perianal Fistulizing Crohn's Disease: Outcomes of Surgical Repairs and Current State of Stem Cell-Based Therapies
Narrative Review on Autoimmune Research, published in Clin Colon Rectal Surg (2025) — summary generated from the PubMed abstract.
- 2025
Clin Colon Rectal Surg - Level AMeta-analysisPubMed
Efficacy of mesenchymal stem cell-based therapies in the treatment of perianal fistulizing Crohn's disease: a systematic review and meta-analysis.
Meta-analysis with a reported sample of 596 on Autoimmune Research, published in Stem Cell Res Ther (2025) — summary generated from the PubMed abstract.
- 2025
- n = 596
Stem Cell Res Ther6 citations - Level BClinical TrialEurope PMC
Stem cell- and extracellular vesicle-based therapies for perianal fistulizing Crohn's disease: An updated review
Clinical Trial on Chronic Wound, Autoimmune Research, published in World J Gastroenterol (2025) — summary generated from the PubMed abstract.
- 2025
World J Gastroenterol - Level DNarrative ReviewEurope PMC
Management and Treatment of Perianal Fistulizing Crohn's Disease
Narrative Review on Autoimmune Research, published in Clin Exp Gastroenterol (2025) — summary generated from the PubMed abstract.
- 2025
Clin Exp Gastroenterol - Level CCohort StudyPubMed
Real-life effectiveness of allogeneic expanded adipose-derived mesenchymal stem cell therapy for perianal fistulizing refractory Crohn's disease.
Cohort Study with a reported sample of 36 on Scar, Autoimmune Research, published in Clin Res Hepatol Gastroenterol (2024) — summary generated from the PubMed abstract.
- 2024
- n = 36
Clin Res Hepatol Gastroenterol - Level CCohort StudyPubMed
Efficacy of cx601 (darvadstrocel) for the treatment of perianal fistulizing Crohn's disease-A prospective nationwide multicenter cohort study.
Cohort Study with a reported sample of 8 on Scar, Autoimmune Research, published in Wien Klin Wochenschr (2023) — summary generated from the PubMed abstract.
- 2023
- n = 8
Wien Klin Wochenschr9 citations - Level ASystematic ReviewPubMed
Effectiveness and safety of darvadstrocel in patients with complex perianal fistulizing Crohn's disease: a systematic review.
Systematic Review on Autoimmune Research, published in Ann Gastroenterol (2023) — summary generated from the PubMed abstract.
- 2023
Ann Gastroenterol6 citations - Level BRandomized Controlled TrialPubMed
Follow-up Study to Evaluate the Long-term Safety and Efficacy of Darvadstrocel (Mesenchymal Stem Cell Treatment) in Patients With Perianal Fistulizing Crohn's Disease: ADMIRE-CD Phase 3 Randomized Controlled Trial.
Randomized Controlled Trial with a reported sample of 25 on Autoimmune Research, published in Dis Colon Rectum (2022) — summary generated from the PubMed abstract.
- 2022
- n = 25
Dis Colon Rectum103 citations - Level BRandomized Controlled TrialPubMed
INSPECT: A Retrospective Study to Evaluate Long-term Effectiveness and Safety of Darvadstrocel in Patients With Perianal Fistulizing Crohn's Disease Treated in the ADMIRE-CD Trial.
Randomized Controlled Trial on Autoimmune Research, published in Inflamm Bowel Dis (2022) — summary generated from the PubMed abstract.
- 2022
Inflamm Bowel Dis40 citations - Level BClinical TrialEurope PMC
The Optimal Management of Fistulizing Crohn's Disease: Evidence beyond Randomized Clinical Trials
Clinical Trial on Autoimmune Research, published in J Clin Med (2022) — summary generated from the PubMed abstract.
- 2022
J Clin Med20 citations - Level BClinical TrialPubMed
Durable Response in Patients With Refractory Fistulizing Perianal Crohn's Disease Using Autologous Mesenchymal Stem Cells on a Dissolvable Matrix: Results from the Phase I Stem Cell on Matrix Plug Trial.
Clinical Trial with a reported sample of 20 on Autoimmune Research, published in Dis Colon Rectum (2022) — summary generated from the PubMed abstract.
- 2022
- n = 20
Dis Colon Rectum15 citations - Level DNarrative ReviewEurope PMC
Recent advances in the management of perianal fistulizing Crohn's disease: lessons for the clinic
Narrative Review on Autoimmune Research, published in Expert Rev Gastroenterol Hepatol (2019) — summary generated from the PubMed abstract.
- 2019
Expert Rev Gastroenterol Hepatol31 citations - Level BRandomized Controlled TrialPubMed
Cx601 (darvadstrocel) for the treatment of perianal fistulizing Crohn's disease.
Randomized Controlled Trial on Chronic Inflammation, Autoimmune Research, published in Expert Opin Biol Ther (2019) — summary generated from the PubMed abstract.
- 2019
Expert Opin Biol Ther - Level CCase Report / SeriesEurope PMC
Magnetic resonance imaging may predict deep remission in patients with perianal fistulizing Crohn's disease
Case Report / Series with a reported sample of 7 on Autoimmune Research, published in World J Gastroenterol (2017) — summary generated from the PubMed abstract.
- 2017
- n = 7
World J Gastroenterol22 citations - Level CProspective StudyPubMed
Fistulizing Crohn's Disease.
Prospective Study on Autoimmune Research, published in Clin Transl Gastroenterol (2017) — summary generated from the PubMed abstract.
- 2017
Clin Transl Gastroenterol25 citations - Level DNarrative ReviewEurope PMC
Multidisciplinary and evidence-based management of fistulizing perianal Crohn's disease
Narrative Review on Autoimmune Research, published in World J Gastrointest Pathophysiol (2014) — summary generated from the PubMed abstract.
- 2014
World J Gastrointest Pathophysiol24 citations - Level BRandomized Controlled TrialEurope PMC
Surgical treatment of perianal fistulizing Crohn's disease: from lay-open to cell-based therapy--an overview
Randomized Controlled Trial on Scar, Autoimmune Research, published in ScientificWorldJournal (2014) — summary generated from the PubMed abstract.
- 2014
ScientificWorldJournal13 citations
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406